These TYK2 mutations (P760L and G761V) are located in two adjacent codons of the pseudokinase domain and have been proposed, based on in silico predictions, as activating mutations predisposing to the development of ALL. This evidence concerns the gene TYK2 and acute lymphoblastic leukemia.